Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GME.DE Stock Summary
Top 10 Correlated ETFs
GME.DE
In the News
GME.DE Financial details
Company Rating
Buy
Market Cap
23.23M
Income
838.58K
Revenue
19.52M
Book val./share
-
Cash/share
-
Dividend
0.15
Dividend %
2.73%
Employees
188
Optionable
No
Shortable
Yes
Earnings
20 Jun 2024
P/E
73.1
Forward P/E
20.57
PEG
5.63
P/S
2.12
P/B
1.31
P/C
-
P/FCF
101.88
Quick Ratio
8.48
Current Ratio
13.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.15
EPS next Y
0.21
EPS next Q
-
EPS this Y
182.74%
EPS next Y
35.92%
EPS next 5Y
35.92%
EPS last 5Y
-3.75%
Revenue last 5Y
3.73%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-20%
SMA50
-33.33%
SMA100
-33.33%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.03%
Gross Margin
59%
Oper. Margin
8%
Profit Margin
3%
Payout
-
Shs Outstand
5.43M
Shs Float
3.35M
-
-
-
-
Target Price
-
52W Range
3.7-7.88
52W High
-38.29%
52W Low
+44%
RSI
41
Rel Volume
2.72
Avg Volume
1.17K
Volume
3.18K
Perf Week
8%
Perf Month
-21.45%
Perf Quarter
-28.6%
Perf Half Y
-30.32%
-
-
-
-
Beta
-0.021
-
-
Volatility
0.22%, 0.51%
Prev Close
0%
Price
4.32
Change
0%
GME.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.35 | 4.01 | 5.55 | 4.98 | 4.75 | |
Net income per share | 0.23 | 0.06 | 0.41 | 0.07 | 0.19 | |
Operating cash flow per share | 0.27 | 0.31 | 0.79 | 0.19 | 0.48 | |
Free cash flow per share | -0.77 | -0.29 | 0.23 | -0.07 | -0.02 | |
Cash per share | 1.58 | 1.93 | 2.07 | 1.31 | 2 | |
Book value per share | 4.1 | 4.01 | 4.1 | 3.74 | 4.1 | |
Tangible book value per share | 3.88 | 3.43 | 3.4 | 2.92 | 3.57 | |
Share holders equity per share | 4.1 | 4.01 | 4.1 | 3.74 | 4.1 | |
Interest debt per share | 0.78 | 1.62 | 2.1 | 1.91 | 1.74 | |
Market cap | 46.58M | 43.46M | 55.89M | 42.03M | 26.79M | |
Enterprise value | 44.6M | 47.1M | 61.17M | 49.08M | 27.35M | |
P/E ratio | 40.38 | 149.94 | 27.32 | 126.34 | 26.18 | |
Price to sales ratio | 2.16 | 2.19 | 2.03 | 1.71 | 1.04 | |
POCF ratio | 34.58 | 28.22 | 14.27 | 45.83 | 10.28 | |
PFCF ratio | -12.25 | -30.78 | 49.19 | -119.05 | -201.42 | |
P/B Ratio | 2.29 | 2.19 | 2.75 | 2.27 | 1.2 | |
PTB ratio | 2.29 | 2.19 | 2.75 | 2.27 | 1.2 | |
EV to sales | 2.07 | 2.37 | 2.23 | 1.99 | 1.06 | |
Enterprise value over EBITDA | 15.65 | 19.84 | 14.42 | 21.33 | 9.55 | |
EV to operating cash flow | 33.11 | 30.58 | 15.62 | 53.53 | 10.49 | |
EV to free cash flow | -11.73 | -33.36 | 53.84 | -139.04 | -205.61 | |
Earnings yield | 0.02 | 0.01 | 0.04 | 0.01 | 0.04 | |
Free cash flow yield | -0.08 | -0.03 | 0.02 | -0.01 | 0 | |
Debt to equity | 0.17 | 0.39 | 0.5 | 0.5 | 0.42 | |
Debt to assets | 0.11 | 0.23 | 0.28 | 0.27 | 0.24 | |
Net debt to EBITDA | -0.7 | 1.53 | 1.25 | 3.07 | 0.19 | |
Current ratio | 3.51 | 2.96 | 2.73 | 2.33 | 6.57 | |
Interest coverage | 4.02 | 4.53 | 11.41 | 4.12 | 7.73 | |
Income quality | 1.62 | 5.31 | 2.06 | 2.75 | 2.55 | |
Dividend Yield | 0.05 | 0.05 | 0.02 | 0.05 | 0.02 | |
Payout ratio | 2.02 | 6.83 | 0.61 | 5.95 | 0.64 | |
Sales general and administrative to revenue | 0.13 | 0.12 | 0.1 | 0.14 | 0 | |
Research and developement to revenue | 0 | 0.07 | 0.06 | 0.06 | 0.05 | |
Intangibles to total assets | 0.03 | 0.07 | 0.09 | 0.12 | 0.11 | |
Capex to operating cash flow | -3.82 | -1.92 | -0.71 | -1.38 | -1.05 | |
Capex to revenue | -0.24 | -0.15 | -0.1 | -0.05 | -0.11 | |
Capex to depreciation | -6.32 | -2.26 | -2.12 | -0.74 | -1.86 | |
Stock based compensation to revenue | 0 | -0.01 | 0 | 0 | 0 | |
Graham number | 4.64 | 2.3 | 6.17 | 2.38 | 4.17 | |
ROIC | 0.05 | 0.01 | 0.07 | 0.02 | 0.03 | |
Return on tangible assets | 0.04 | 0.01 | 0.06 | 0.01 | 0.03 | |
Graham Net | 0.85 | 0.38 | 0.13 | -0.37 | 0.43 | |
Working capital | 13.48M | 13.76M | 13.57M | 11.18M | 19.77M | |
Tangible asset value | 19.22M | 16.98M | 16.85M | 14.47M | 19.45M | |
Net current asset value | 9.59M | 6.7M | 5.33M | 3.68M | 8.68M | |
Invested capital | 0.17 | 0.39 | 0.5 | 0.5 | 0.42 | |
Average receivables | 2.65M | 2.98M | 3.52M | 4.11M | 3.74M | |
Average payables | 1.3M | 1.51M | 1.46M | 1.47M | 1.47M | |
Average inventory | 7.04M | 7.58M | 7.59M | 7.92M | 8.14M | |
Days sales outstanding | 44.75 | 60.99 | 49.4 | 66.69 | 42.06 | |
Days payables outstanding | 80.24 | 83.47 | 55.6 | 62.76 | 28.36 | |
Days of inventory on hand | 364.2 | 465.35 | 270.16 | 374.75 | 145.13 | |
Receivables turnover | 8.16 | 5.98 | 7.39 | 5.47 | 8.68 | |
Payables turnover | 4.55 | 4.37 | 6.57 | 5.82 | 12.87 | |
Inventory turnover | 1 | 0.78 | 1.35 | 0.97 | 2.51 | |
ROE | 0.06 | 0.01 | 0.1 | 0.02 | 0.05 | |
Capex per share | -1.04 | -0.6 | -0.56 | -0.26 | -0.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.97 | 1.41 | 1.09 | 1.09 | 0 | |
Net income per share | 0.03 | 0.02 | 0.06 | 0.06 | 0 | |
Operating cash flow per share | 0 | 0.2 | 0.13 | 0.13 | 0 | |
Free cash flow per share | -0.1 | 0.17 | 0.11 | 0.11 | 0 | |
Cash per share | 1.59 | 2 | 2.01 | 2.01 | 0 | |
Book value per share | 3.4 | 4.1 | 4.21 | 4.21 | 0 | |
Tangible book value per share | 2.72 | 3.33 | 3.5 | 3.48 | 0 | |
Share holders equity per share | 3.4 | 4.1 | 4.21 | 4.21 | 0 | |
Interest debt per share | 1.59 | 1.06 | 1.5 | 1.5 | 0 | |
Market cap | 39.48M | 26.79M | 42.33M | 40.43M | 0 | |
Enterprise value | 41.62M | 18.05M | 33.61M | 39.86M | 0 | |
P/E ratio | 49.83 | 50.3 | 30.01 | 28.66 | 0 | |
Price to sales ratio | 6.17 | 3.48 | 7.16 | 6.84 | 0 | |
POCF ratio | -1.36K | 25.01 | 61.58 | 58.81 | 0 | |
PFCF ratio | -62.67 | 29.02 | 71.81 | 68.59 | 0 | |
P/B Ratio | 1.76 | 1.2 | 1.85 | 1.77 | 0 | |
PTB ratio | 1.76 | 1.2 | 1.85 | 1.77 | 0 | |
EV to sales | 6.5 | 2.34 | 5.69 | 6.74 | 0 | |
Enterprise value over EBITDA | 53.41 | 14.24 | 35.01 | 41.52 | 0 | |
EV to operating cash flow | -1.44K | 16.86 | 48.89 | 57.98 | 0 | |
EV to free cash flow | -66.07 | 19.56 | 57.02 | 67.62 | 0 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0 | |
Free cash flow yield | -0.02 | 0.03 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.47 | 0.26 | 0.36 | 0.36 | 0 | |
Debt to assets | 0.26 | 0.15 | 0.21 | 0.21 | 0 | |
Net debt to EBITDA | 2.75 | -6.89 | -9.08 | -0.6 | 0 | |
Current ratio | 2.3 | 2.7 | 19.53 | 13.99 | 0 | |
Interest coverage | 8.29 | -27.88 | 0 | 0 | 0 | |
Income quality | -0.13 | 8.04 | 1.95 | 1.95 | 0 | |
Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
Payout ratio | 3.3 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.1 | 0.11 | 0.11 | 0.11 | 0 | |
Capex to operating cash flow | 20.72 | -0.14 | -0.14 | -0.14 | 0 | |
Capex to revenue | -0.09 | -0.02 | -0.02 | -0.02 | 0 | |
Capex to depreciation | -1.37 | -0.78 | -0.27 | -0.27 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.52 | 1.5 | 2.48 | 2.48 | 0 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Return on tangible assets | 0.01 | 0 | 0.01 | 0.01 | 0 | |
Graham Net | -0.18 | 0.2 | 0.4 | 0.41 | 0 | |
Working capital | 13.76M | 14.69M | 22.26M | 21.88M | 0 | |
Tangible asset value | 17.97M | 18.11M | 19M | 18.9M | 0 | |
Net current asset value | 5.89M | 7.16M | 8.49M | 8.6M | 0 | |
Invested capital | 0.47 | 0.26 | 0.36 | 0.36 | 0 | |
Average receivables | 3.55M | 3.68M | 3.52M | 3.32M | 1.69M | |
Average payables | 1.43M | 1.47M | 1.26M | 1.01M | 507.44K | |
Average inventory | 8.25M | 7.63M | 7.28M | 7.54M | 3.77M | |
Days sales outstanding | 50.27 | 44.14 | 49.78 | 51.45 | 0 | |
Days payables outstanding | 55.21 | 40.01 | 57.59 | 57.59 | 0 | |
Days of inventory on hand | 318.07 | 185.84 | 427.81 | 427.81 | 0 | |
Receivables turnover | 1.79 | 2.04 | 1.81 | 1.75 | 0 | |
Payables turnover | 1.63 | 2.25 | 1.56 | 1.56 | 0 | |
Inventory turnover | 0.28 | 0.48 | 0.21 | 0.21 | 0 | |
ROE | 0.01 | 0.01 | 0.02 | 0.02 | 0 | |
Capex per share | -0.09 | -0.03 | -0.02 | -0.02 | 0 |
GME.DE Frequently Asked Questions
What is Geratherm Medical AG stock symbol ?
Geratherm Medical AG is a DE stock and trading under the symbol GME.DE
What is Geratherm Medical AG stock quote today ?
Geratherm Medical AG stock price is $4.32 today.
Is Geratherm Medical AG stock public?
Yes, Geratherm Medical AG is a publicly traded company.